BACKGROUND: Experimental autoimmune uveitis (EAU) is a highly organ-specific autoimmune disease in which the target is the retinal photoreceptors. It is well recognized as a model of uveoretinitis in humans.
Forrester, J. V. +3 more
core
Artesunate ameliorates experimental autoimmune uveitis by inhibiting the LCN2-STAT3 axis and suppressing microglial activation. [PDF]
Gu J +6 more
europepmc +1 more source
Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation. [PDF]
Lee JY +5 more
europepmc +1 more source
Too Much of a Good Thing: Extended Duration of Gut Microbiota Depletion Reverses Protection From Experimental Autoimmune Uveitis. [PDF]
Salvador R +7 more
europepmc +1 more source
The Therapeutic Effects of Purified Cortrophin Gel on Experimental Autoimmune Uveitis. [PDF]
Taylor AW, Kim M, Zhao JL, Ng TF.
europepmc +1 more source
Correction: Retinal endothelial cell phenotypic modifications during experimental autoimmune uveitis: a transcriptomic approach. [PDF]
Lipski DA +6 more
europepmc +1 more source
Effect of Dipyridamole on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Pathogenicity. [PDF]
Chen B +9 more
europepmc +1 more source
Single-cell analysis of immune cells on gingiva-derived mesenchymal stem cells in experimental autoimmune uveitis. [PDF]
Gao Y +11 more
europepmc +1 more source
The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitis. [PDF]
Shome A +3 more
europepmc +1 more source
Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy. [PDF]
Crabtree E +9 more
europepmc +1 more source

